AR055549A1 - Gel de plaquetas semisintetico y procedimiento par la preparacion del mismo - Google Patents

Gel de plaquetas semisintetico y procedimiento par la preparacion del mismo

Info

Publication number
AR055549A1
AR055549A1 ARP050105471A ARP050105471A AR055549A1 AR 055549 A1 AR055549 A1 AR 055549A1 AR P050105471 A ARP050105471 A AR P050105471A AR P050105471 A ARP050105471 A AR P050105471A AR 055549 A1 AR055549 A1 AR 055549A1
Authority
AR
Argentina
Prior art keywords
platelet
procedure
preparation
semisintetic
same
Prior art date
Application number
ARP050105471A
Other languages
English (en)
Inventor
Virgilio Evangelista
Original Assignee
Advance Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Holdings Ltd filed Critical Advance Holdings Ltd
Publication of AR055549A1 publication Critical patent/AR055549A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Gel de plaquetas semisintético que comprende un plasma rico en plaquetas, por lo menos un activador de plaquetas y un polímero biocompatible seleccionado de entre el grupo que comprende carbomeros, polialquilenglicoles, poloxámeros, poliésteres, poliéteres, polianhídridos, poliacrilatos, acetatos de polivinilo, polivinilpirrolidonas, polisacáridos y derivados de los mismos. Procedimiento para la preparacion de un gel de plaquetas semisintético que comprende las etapas siguientes: (a) mezclar un plasma rico en plaquetas con por lo menos un activador de plaquetas, y antes de que comience la formacion del coágulo, (b) anadir la mezcla obtenida de este modo a un polímero biocompatible seleccionado de entre el grupo que comprende carbomeros, polialquilenglicoles, poloxámeros, poliésteres, poliéteres, polianhídridos, poliacrilatos, acetatos de polivinilo, polivinilpirrolidonas, polisacáridos y derivados de los mismos.
ARP050105471A 2004-12-24 2005-12-22 Gel de plaquetas semisintetico y procedimiento par la preparacion del mismo AR055549A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000638A ITRM20040638A1 (it) 2004-12-24 2004-12-24 Gel piastrinico semisintetico e metodo per la sua preparazione.

Publications (1)

Publication Number Publication Date
AR055549A1 true AR055549A1 (es) 2007-08-22

Family

ID=34956722

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105471A AR055549A1 (es) 2004-12-24 2005-12-22 Gel de plaquetas semisintetico y procedimiento par la preparacion del mismo

Country Status (10)

Country Link
US (2) US8168230B2 (es)
EP (2) EP2281588A1 (es)
JP (1) JP5298307B2 (es)
AR (1) AR055549A1 (es)
AU (1) AU2005246958B2 (es)
BR (1) BRPI0505533A (es)
CA (1) CA2531258A1 (es)
IT (1) ITRM20040638A1 (es)
NZ (1) NZ544403A (es)
ZA (1) ZA200510444B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
WO2003099412A1 (en) 2002-05-24 2003-12-04 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20070093748A1 (en) * 2005-06-23 2007-04-26 Medtronic Vascular, Inc. Methods and systems for treating injured cardiac tissue
US20070172472A1 (en) * 2005-06-23 2007-07-26 Asha Nayak Methods and Systems for Treating Injured Cardiac Tissue
US20070014784A1 (en) * 2005-06-23 2007-01-18 Medtronic Vascular, Inc. Methods and Systems for Treating Injured Cardiac Tissue
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
ITRM20060289A1 (it) * 2006-05-31 2007-12-01 Ranieri Cancedda Bio membrana ingegnerizzata osteo angiogenica e suoi usi per la rigenerazione di tessuto osseo
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2146794B1 (en) 2007-04-12 2016-10-19 Biomet Biologics, LLC Buoy suspension fractionation system
EP2567692B1 (en) 2008-02-27 2016-04-06 Biomet Biologics, LLC Use of a device for obtaining interleukin-1 receptor antagonist rich solutions
EP2254991B1 (en) * 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
GB2460815A (en) * 2008-04-04 2009-12-16 Kays Medical A sterilisable gel formulation comprising calcium gluconate
JP5521235B2 (ja) * 2008-06-12 2014-06-11 ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 高強度フィブリン成形体及び人工靭帯
WO2010020247A1 (en) * 2008-08-22 2010-02-25 Reapplix Aps Multilayered blood product
CA2743841C (en) * 2008-11-13 2020-09-01 Eastern Virginia Medical School Activation and aggregation of human platelets and formation of platelet gels by nanosecond pulsed electric fields
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
ES2648090T3 (es) * 2009-06-11 2017-12-28 Universitat Autònoma De Barcelona Uso de PRP gelificado (gel de plaquetas) para la reconstrucción volumétrica de la mama
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
GB201004072D0 (en) * 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
US8586324B2 (en) 2011-08-15 2013-11-19 Biomet Biologics, Llc Method and apparatus to create autologous clotting serum
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
EP2986323A4 (en) * 2013-04-16 2016-10-19 Univ Case Western Reserve NEUTRALLY LOADED SYNTHETIC BLOOD PLATES TO REDUCE A COMPLEMENT REACTION
KR20170102319A (ko) * 2014-12-31 2017-09-08 안트로제네시스 코포레이션 혈소판을 분리하는 방법
US9962462B2 (en) 2015-06-11 2018-05-08 Case Western Reserve University Dry spray on hemostatic system
KR20180108649A (ko) 2016-01-06 2018-10-04 레아플릭스 에이피에스 차후의 자가 사용을 위한 응혈 촉진 인자
TR201815514A2 (tr) 2018-10-18 2018-11-21 T Biyoteknoloji Laboratuvar Estetik Medikal Kozmetik San Tic Ltd Sti Trombosi̇t zengi̇n plazma elde etmek üzere bi̇r yöntem
US20220088589A1 (en) 2019-01-21 2022-03-24 Eclipse Medcorp, Llc Methods, Systems and Apparatus for Separating Components of a Biological Sample
PT3996673T (pt) * 2019-07-08 2023-10-24 Theravet Sa Um método para a preparação de uma composição de formação de gel
US11951134B2 (en) 2019-09-30 2024-04-09 North Carolina State University Cationic platelet lysate compositions and related methods
KR20220091580A (ko) 2019-10-31 2022-06-30 이클립스 메드코프 엘엘씨 샘플의 구성요소들을 분리하기 위한 시스템, 방법 및 장치
CN110693906A (zh) * 2019-11-21 2020-01-17 四川中清科华医疗器械有限公司 一种自体白细胞和血小板血浆综合提取方法
CN114225028B (zh) * 2021-11-22 2023-06-23 深圳大学 一种磁性可降解血液凝胶及其制备方法、应用
CN115068691B (zh) * 2022-06-10 2023-04-25 华中科技大学 一种可注射生物活性水凝胶及其制备方法和应用
CN115137751B (zh) * 2022-07-18 2024-05-28 东莞市妇幼保健院 一种富血小板血浆的处理方法及其在抑制妊娠纹中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB495675A (en) 1937-01-08 1938-11-17 Hoffmann La Roche Process for the manufacture of easily water-soluble calcium double salts of ascorbicacid
US5834418A (en) 1996-03-20 1998-11-10 Theratechnologies, Inc. Process for the preparation of platelet growth factors extract
US6524568B2 (en) 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
US6322785B1 (en) 1999-03-02 2001-11-27 Natrex Technologies Methods and compositions for bone graft implants
EP1093390B1 (en) 1999-04-12 2013-05-08 Harvest Technologies Corporation Method and apparatus for producing platelet rich plasma and/or platelet concentrate
BR0112109A (pt) 2000-06-29 2007-05-29 Biosyntech Canada Inc composição e método para a correção e regeneração de cartilagem e outros tecidos
WO2002080991A2 (en) 2001-04-09 2002-10-17 Medtronic, Inc. System for the production of autologous platelet gel
US20030152639A1 (en) 2001-07-03 2003-08-14 Calvin Britton Novel wound healing composition not containing bovine-derived activating reagents
SI2298338T1 (sl) 2002-09-16 2012-11-30 Agennix Inc Laktoferinski sestavki in postopki za zdravljenjekožnih ran
US20040197319A1 (en) 2003-03-24 2004-10-07 Paul Harch Wound healing composition derived from low platelet concentration plasma
US7074765B2 (en) * 2003-05-01 2006-07-11 The Regents Of The University Of Michigan Synthetic peptide analogs of Arg-Pro-Pro-Gly-Phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

Also Published As

Publication number Publication date
ZA200510444B (en) 2006-09-27
US20120213755A1 (en) 2012-08-23
BRPI0505533A (pt) 2006-09-12
JP5298307B2 (ja) 2013-09-25
ITRM20040638A1 (it) 2005-03-24
CA2531258A1 (en) 2006-06-24
US8168230B2 (en) 2012-05-01
EP1674115A1 (en) 2006-06-28
JP2006181365A (ja) 2006-07-13
US20060140923A1 (en) 2006-06-29
EP2281588A1 (en) 2011-02-09
AU2005246958B2 (en) 2011-11-03
NZ544403A (en) 2007-07-27
AU2005246958A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
AR055549A1 (es) Gel de plaquetas semisintetico y procedimiento par la preparacion del mismo
DOP2006000252A (es) Profarmacos mutuos de glucosamina y glucosamina/anti-inflamatorio, composiciones, y metodos
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
EA200701841A1 (ru) Новые фармацевтические композиции для лечения тромбоза
CR8402A (es) Indazol-o-glucosidos sustitutos
PA8652701A1 (es) Derivados de quinolina e isoquinolina 5-sustitutos, un procedimiento para su preparacion y su uso como inhibidores de la inflamacion
EA200301091A1 (ru) Противоопухолевые комбинации, такие как рапамицин вместе с гемцитабином или фторурацилом
UY28342A1 (es) Nuevos compuestos
CR8273A (es) Administracion de ligandos de tlr7 y profarmacos de los mismos para el tratamiento de la infeccion por el virus de hepetitis c
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
DK1682530T3 (da) Pyrrolsubstituerede indoler som inhibitorer af PAI-1
TW200517381A (en) Bicyclic heteroaryl derivatives
MXPA06000407A (es) Isomero c cci-779.
EA200401169A1 (ru) Аминометилзамещенные тетрациклиновые соединения
CL2021001753A1 (es) Compuestos derivados de 2,4-diaminoquinazolina; composición farmacéutica; y su uso para el tratamiento de una infección vírica, cáncer, entre otras (divisional de solicitud 202002253).
CR7804A (es) Terapia combinada para el tratamiento de leucemia aguda y sindrome mielodisplasico
NO20071871L (no) Fosfoindoler som HIV-inhibitorer.
BRPI0607351A2 (pt) métodos para tratamento de linfomas empregando uma combinação de agente quimioterapêutico e il-2 e opcionalmente um anticorpo anti-cd20
UY27894A1 (es) Derivados de cinamida.
UY27208A1 (es) Una combinación que comprende combretastatina y agentes anticarcinógenos.
CR11248A (es) Compuestos anti-virales, composiciones y metodos de uso
AR035438A1 (es) Composicion de alimento compuesto que comprende un gel y el proceso para su preparacion.
AR045155A1 (es) Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos
ES2524585T3 (es) Sistema catalizador para la polimerización de olefinas, su producción y su uso

Legal Events

Date Code Title Description
FA Abandonment or withdrawal